The global weight loss industry was valued at $16.3 billion in 2025, yet peer-reviewed clinical validation of program outcomes remains uneven across the categoryRandomized controlled trials control ...

Millions of older Americans may have access for the first time to obesity drugs at a low price of $50 a month starting in ...

After a trial run, we discovered how Equinox's Optimize program transforms fitness, nutrition, and sleep into a tailored ...

U.S. school districts worry it could get even more expensive to prepare a meal under new federal dietary guidelines, as they ...

Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need ...

Side effects like nausea, vomiting, diarrhea and constipation are common soon after starting GLP-1s or increasing the drug’s dosage. A nutrient-dense diet and regular exercise a ...

A major new analysis suggests semaglutide (Ozempic, Wegovy) works remarkably well in adults over 65, helping many lose ...

Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work ...

According to Research and Markets, the global health coaching market is projected to grow in value from $20.53 billion in 2025 to $22.5 billion in 2026. The ...

New clinical findings show Optavia’s Optimal Weight 5 & 1 Plan preserved 98% of lean mass over 16 weeks, underscoring its focus on metabolic health beyond weight loss. The company positions its ...

The Trump administration's promised Medicare pilot program for GLP-1 weight-lossdrugs was positioned to help cover the costs of these medications, helpingseniors avoidwasting money in retirement while ...